v3.22.4
STOCKHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2022
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
Common Stock
The Company is authorized to issue up to 250,000,000 shares of common stock, of which 45,927,790 and 44,734,308 were issued and outstanding at December 31, 2022 and 2021, respectively.
Preferred Stock
The Company is authorized to issue up to 5,000,000 shares of preferred stock. No preferred stock was issued or outstanding at either December 31, 2022 or 2021.
Accumulated Other Comprehensive (Loss) Income
    The following table illustrates the changes in the balances of the Company’s accumulated other comprehensive (loss) income for the periods presented (in thousands):
Net Unrealized Gains
(Losses) From Available-For-Sale Investments		Unrealized Foreign Currency TranslationAccumulated Other Comprehensive (Loss) Income
Balance at December 31, 2019$322 $— $322 
Net unrealized loss on investments(3)— (3)
Foreign currency translation adjustments— (1)(1)
Balance at December 31, 2020319 (1)318 
Net unrealized loss on investments, net of tax(1)
(180)— (180)
Foreign currency translation adjustments— 29 29 
Balance at December 31, 2021139 28 167 
Net unrealized loss on investments, net of tax(1)
(662)— (662)
Foreign currency translation adjustments— 115 115 
Balance at December 31, 2022$(523)$143 $(380)
(1) Net of a $0.2 million and $0.1 million tax benefit for the years ended December 31, 2022 and 2021, respectively.